| UHC Commercial Medical & Drug | Spinraza® (Nusinersen) – Commercial Medical Benefit Drug Policy | 2026-09-01 |
| UHC Commercial Medical & Drug | Surgery of the Shoulder – Commercial and Individual Exchange Medical Policy | 2026-09-01 |
| BCBS Highmark Delaware | Complement Inhibitors | 2026-09-01 |
| BCBS Highmark Delaware | Denosumab (Prolia, Xgeva) and Denosumab Biosimilars | 2026-09-01 |
| BCBS Highmark NY and West NY | Site of Care | 2026-09-01 |
| UHC Medicaid Medical & Drug | Autologous Cellular Therapy – Community Plan Medical Policy | 2026-09-01 |
| UHC Medicaid Medical & Drug | Denosumab – Community Plan Medical Benefit Drug Policy | 2026-09-01 |
| UHC Medicaid Medical & Drug | Electric Tumor Treatment Field Therapy – Community Plan Medical Policy | 2026-09-01 |
| UHC Medicaid Medical & Drug | Genetic Testing for Neurological Disorders – Community Plan Medical Policy | 2026-09-01 |
| UHC Medicaid Medical & Drug | Glaucoma Surgical Treatments – Community Plan Medical Policy | 2026-09-01 |